NLRP3 inflammasome inhibitors

The present invention relates to novel pyridazin-3-yl phenol compounds of Formula (I):wherein R1, R2, R3, R4, R5 and Z are defined herein, which inhibit NOD-like receptor protein 3 (NLRP3) inflammasome activity. The invention further relates to the processes for their preparation, pharmaceutical com...

Full description

Saved in:
Bibliographic Details
Main Authors Gommermann, Nina, Mattes, Henri, Mackay, Angela, Solovay, Catherine Fooks, Velcicky, Juraj, Farady, Christopher, Stiefl, Nikolaus Johannes, von Matt, Anette, Janser, Philipp, Smith, Nichola, Vangrevelinghe, Eric
Format Patent
LanguageEnglish
Published 28.12.2021
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to novel pyridazin-3-yl phenol compounds of Formula (I):wherein R1, R2, R3, R4, R5 and Z are defined herein, which inhibit NOD-like receptor protein 3 (NLRP3) inflammasome activity. The invention further relates to the processes for their preparation, pharmaceutical compositions and medicaments containing them, and their use in the treatment of diseases and disorders mediated by NLRP3.
Bibliography:Application Number: US202016874862